CELIA
OREJA GUEVARA
Profesora asociada de Ciencias de la Salud
Heinrich Heine University Düsseldorf
Düsseldorf, AlemaniaPublicaciones en colaboración con investigadores/as de Heinrich Heine University Düsseldorf (11)
2024
-
Individual Prognostication of Disease Activity and Disability Worsening in Multiple Sclerosis With Retinal Layer Thickness z Scores
Neurology: Neuroimmunology and NeuroInflammation, Vol. 11, Núm. 5
2022
-
Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in
Frontiers in Immunology, Vol. 13
-
Using personalized prognosis in the treatment of relapsing multiple sclerosis: A practical guide
Frontiers in Immunology, Vol. 13
2021
-
Artificial intelligence extension of the OSCAR-IB criteria
Annals of Clinical and Translational Neurology, Vol. 8, Núm. 7, pp. 1528-1542
2020
-
Pediatric NMOSD: A Review and Position Statement on Approach to Work-Up and Diagnosis
Frontiers in Pediatrics, Vol. 8
2018
-
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
The Lancet Neurology, Vol. 17, Núm. 5, pp. 405-415
-
Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meeting
Therapeutic Advances in Neurological Disorders, Vol. 11
2016
-
Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: A cohort study
The Lancet Neurology, Vol. 15, Núm. 6, pp. 574-584
2014
-
Clinical relevance of brain volume measures in multiple sclerosis
CNS Drugs, Vol. 28, Núm. 2, pp. 147-156
-
Specific aspects of modern life for people with multiple sclerosis: Considerations for the practitioner
Therapeutic Advances in Neurological Disorders, Vol. 7, Núm. 2, pp. 137-149
2011
-
Symptomatic therapy in multiple sclerosis: A review for a multimodal approach in clinical practice
Therapeutic Advances in Neurological Disorders, Vol. 4, Núm. 3, pp. 139-168